Vumerity Start Form PDF

Vumerity Start Form PDF - Then fax the Start Form to 1 855 474 3067 Prescriptions are only valid when received via fax Your patient will be contacted by a pharmacy in the VUMERITY Pharmacy Network to arrange for delivery of the prescription Please be sure to fill out all of the sections of the Start Form Incomplete areas may delay the start of treatment

VUMERITY diroximel fumarate is indicated for the treatment of relapsing forms of multiple sclerosis MS to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults Important Safety Information CONTRAINDICATIONS

Vumerity Start Form PDF

Vumerity Start Form PDF

Then, fax the Start Form to 1-855-474-3067. Prescriptions are only valid when received via fax. Your patient will be contacted by a pharmacy in the VUMERITY Pharmacy Network to arrange for delivery of the prescription. Please be sure to fill out all of the sections of the Start Form. Incomplete areas may delay the start of treatment.

1 Fill out the VUMERITY Start Form and bring it to the next appointment with your healthcare provider You can even share this form during a telehealth visit Once the Start Form has been filled out by your healthcare provider they will send it back to Biogen the makers of VUMERITY

Start VUMERITY Diroximel Fumarate

The VUMERITY Start Form Submit Request for Prior Authorization PA and or Exception Review Denial If Necessary Start patients on VUMERITY by completing the Start Form accessible via E Sign DocuSign at Paper form faxed iAssist or VUMERITYhcp to 1 855 474 3067 CoverMyMeds

Start Form PLEGRIDY peginterferon Beta 1a

VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis MS to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults It is not known if VUMERITY is safe and effective in children have had an allergic reaction such as welts hives

Span Class Result Type

Complete a Start Form today The efficacy of VUMERITY is based upon bioavailability studies comparing dimethyl fumarate DMF to VUMERITY in patients with relapsing forms of MS and healthy subjects1 VUMERITY offers the established efficacy of DMF across Studies 1 and 2 In Study 1 and Study 2 pivotal trials DMF demonstrated a 53 and 44

Starting VUMERITY diroximel Fumarate Treatment

E Sign Biogen Start Forms via DocuSign Visit vumerityhcp to initiate the process for completing a Biogen Start Form via DocuSign Clicking on the E Sign Start Form button will launch the DocuSign See VUMERITY example below PowerForm 2 3 Once the DocuSign PowerForm

VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults It is not known if VUMERITY is safe and effective in children Important Safety Information Do not take VUMERITY if you:

Span Class Result Type

VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis MS to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults It is not known if VUMERITY is safe and effective in children Do not take VUMERITY if you

Vumerity Start Form PDF

E Sign Biogen Start Forms via DocuSign Visit vumerityhcp to initiate the process for completing a Biogen Start Form via DocuSign Clicking on the E Sign Start Form button will launch the DocuSign See VUMERITY example below PowerForm 2 3 Once the DocuSign PowerForm

VUMERITY diroximel fumarate is indicated for the treatment of relapsing forms of multiple sclerosis MS to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults Important Safety Information CONTRAINDICATIONS

FAQ VUMERITY diroximel Fumarate